Expands use of Nociscan in groundbreaking trialBROOMFIELD, Colo., April 08, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare ...
Compared with placebo (dummy treatment), antibiotics may reduce back pain slightly and may have some beneficial effect in improving disability in the short term in people with low back pain linked to ...
Video featuring Mr. John Sutcliffe, Lead Clinician at The London Spine Clinic, highlights real-world physician experience with Nociscan in ...
Most nonsurgical and noninterventional treatments for low back pain failed to outperform placebo in a new systematic review and meta-analysis, with just 10% showing only modest pain relief.
LOW BACK PAIN is more than just discomfort. It's the leading cause of disability worldwide according to WHO data—and it can be tough to find the right treatment. Now, new research suggests that taking ...
Explore the latest evidence from UNSW Sydney and NeuRA on non-drug, non-surgical treatments for acute and chronic low back pain (LBP). Based on a Cochrane review of over 97,000 participants, discover ...